Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07741877 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma

Study acronym: 'SARATOGA'
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Study sites: 0 to 2 · Start date changed from estimate of Sep 1, 2026 to Oct 2, 2026 · Eligibility criteria expanded, about 18 words Show 3 more changesShow less
    • Study sites: 0 to 2
    • Start date changed from estimate of Sep 1, 2026 to Oct 2, 2026
    • Eligibility criteria expanded, about 18 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A study of lifileucel (tumor-infiltrating lymphocytes) in adults with advanced soft tissue sarcoma ('SARATOGA')
Trial Details
NCT Number NCT07741877
Lead Sponsor Iovance Biotherapeutics, Inc.
Conditions Sarcoma, Soft Tissue Sarcoma (STS), Advanced Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma (UPS), Dedifferentiated Liposarcoma (DDLPS)
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov